ALINA SARKISYAN: Open Payments
NPI 1376185165 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 30 payments from 9 companies in 2025. Trend: 2023 $658 · 2024 $1,061 · 2025 $1,453
Food & beverage: $1,453
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $360 |
| ABBVIE INC. | 5 | $317 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $223 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $198 |
| INTUITIVE SURGICAL, INC. | 1 | $135 |
| Incyte Corporation | 1 | $127 |
| SHIELD THERAPEUTICS INC | 2 | $41 |
| Ardelyx, Inc. | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
Products named: XIFAXAN, OTEZLA, JARDIANCE, QULIPTA, REPATHA, Da Vinci Surgical System, Opzelura, ACCRUFER.
Industry payments across NY — which companies pay providers there.
